Nanologica AB (publ) (STO:NICA)

Market Cap	97.19M
Revenue (ttm)	20.25M
Net Income (ttm)	-59.03M
Shares Out	88.36M
EPS (ttm)	-0.94
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	145,224
Average Volume	321,183
Open	1.100
Previous Close	1.100
Day's Range	1.100 - 1.170
52-Week Range	0.750 - 6.840
Beta	0.44
RSI	44.12
Earnings Date	Jul 10, 2025

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 16
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NICA

Financial Performance

In 2024, Nanologica AB's revenue was 14.54 million, an increase of 211.17% compared to the previous year's 4.67 million. Losses were -65.63 million, -12.68% less than in 2023.